CodyyyGardner Authors (((Howard Forman)))

7 days 30 days All time Recent Popular
My thoughts on 1-dose vs 2-dose approach.

TL; DR

Wrong questions give you wrong answers.

We assuredly should want 2 doses, the only issue is the timing of 2nd dose. And a brief delay is a risk worth taking.

But let's prioritize >65 year old 2nd doses at same time.

1/9


First, let's start with @VirusesImmunity brilliant thread:

We know enough to know that there is vast benefit from giving substantial immunity to as many as possible as quickly as possible.


We also know that the timing of second dose was never set in stone. Pfizer chose to give second dose at 19-23 days; Moderna chose at 28-31 days. They tested at these levels and proved safety and efficacy. Safety is not at issue with delayed dosing. Efficacy probably is.

3/9

Most of medicine, as practiced, has not been subjected to rigorous clinical trials for various reasons. We weigh available evidence & act accordingly. We pivot when new evidence is available. We should want more RCTs, but they are often unethical or impossible to perform. 4/9

Ideally, Pfizer &/or Moderna would have already done a single dose arm. JNJ is testing both a single-dose & 2-dose regimen. We will have some data in a few weeks on the 1-dose regimen.

But we don't live in an ideal world. We live in the real world.